Litcius/Paper detail

National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial

Christine Rogers, Adrienne N. Cobb, Jan Irene Lloren, Lubna N. Chaudhary, Morgan K. Johnson, Chiang‐Ching Huang, Mediget Teshome, Amanda L. Kong, Puneet Singh, Chandler S. Cortina

2023Breast Cancer Research and Treatment21 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTriple-negative breast cancerBreast cancerInternal medicineOncologyCancerStage (stratigraphy)CohortChemotherapyVeterans AffairsMultivariate analysisPaleontologyBiologyBreast Cancer Treatment StudiesCancer Treatment and PharmacologyBreast Lesions and Carcinomas
National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial | Litcius